Trial Profile
IG-001 in the treatment of lung cancer: a post-marketing surveillance study.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 25 Sep 2015
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary) ; Cisplatin
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 25 Sep 2015 New trial record